Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 620 results for "cadila pharma"

Pharma companies may post healthy numbers on strong global bus...

Lupin, Cadila Healthcare, Torrent Pharma expected to post strong growth, but muted performance seen from Sun Pharma and Dr Reddy's DNA, 5 days ago
Cadila Pharmaceuticals buys BioChromix NewCo Nordic Life Science, 2 weeks ago
Business Standard India

Price hikes...US Congress investigates Indian pharma Cos

This includes Indian pharma companies such as Sun Pharma, Dr Reddy's and Cadila among the 14 pharmaceutical companies under scanner. US Congress has initiated investigation on price hike of ten generic drugs, according to reports. This includes Indian pharma ...
 India Infoline2 weeks ago Ketorolac Tromethamine Injection by Sagent Pharmaceuticals Recalled: AttorneyOne Monitors and Keeps Consumers Informed  Red Orbit2 weeks ago US Congress probes Indian pharma majors for drug price hike  Business Standard India2 weeks ago Aurobindo Pharma becomes fifth most valuable pharma firm  Business Standard India2 weeks ago
[x]  

US price hike probe: Sun Pharma, DRL, Cadila tank 2-5%

This probed seems to be triggered by National Community Pharmacists Association (NCPA) 2013 survey of drug prices. In 2014, the NCPA had written to the US Senate seeking investigation into large upswing in acquisition prices of generic medicines.
 Money Control2 weeks ago Will US price hike probe hit Sun Pharma, DRL, Cadila?  Money Control2 weeks ago DRL, Sun and Cadila arms under US lens for 'soaring' prices  Financial Express2 weeks ago
Rediff.com

Pharma firms to be hit as drug regulator caps prices

In a move that might impact major drug makers such as Ranbaxy, Cipla, Cadila Health, and Lupin, the National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 19 medicines and their 43 different drug packs, including anti-infectives, gastro-intestinal drugs and vaccines. Among multinational companies, Pfizer, Sanofi and Reckitt Benckiser are likely to take a hit. NPPA has notified the ceiling price of these products under the Drugs Price Control Order, 2013. In the absence of ...
 Rediff.com1 month ago Indian Pharma regulator cuts prices of 43 drug formulations  Domain-B1 month ago NPPA caps prices of 43 drug formulation packs  Business Standard India1 month ago Pharma majors to be hit as drug regulator caps prices  Business Standard India1 month ago
[x]  
Business Standard India

Sensex consolidates; pharma surges; FMCG autos decline

12:55pm Cadila Healthcare at new high Cadila Healthcare shares hit a record high of Rs 1,239 on the Bombay Stock Exchange on Wednesday after getting approval from US Food and Drug Administration for anti-viral drug Acyclovir. "Zydus Cadila has ...
 Moneycontrol.com2 months ago Cadila Healthcare: Twin engines to spur growth  Business Standard India4 weeks ago Twin engines to spur Cadila's growth  Business Standard India4 weeks ago

Sun Pharmaceutical Industries, Dr Reddy's face US action on price hikes up to 8,000%

Shares of three Indian pharma companies Cadila Healthcare, Dr Reddy's Laboratories and Sun Pharmaceutical Industries on Wednesday fell 5% on news that the US Senate has initiated an investigation against them regarding huge spikes in prices of ...
 DNA India2 weeks ago Sun, Reddy's face US action on price spikes [DNA : Daily News & Analysis (India)]  Pharmacy Choice2 weeks ago After India success, Cadila to take innovator drug to US [DNA : Daily News & Analysis (India)]  TMC Net1 month ago
Business Standard

Cadila Pharma plans for manufacturing facility in Bahrain

The company has already received approvals from Gulf Central Committee for Drug Registrations for many of its drugs Press Trust of India | Dubai, UAE September 9, 2014 Last Updated at 15:41 IST The Gujarat-based generic drug manufacturer Cadila ...
 Business Standard1 month ago Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets  Indian-Commodity1 month ago Zydus Cadila gets USFDA nod to market Telmisartan tablets in US  Indian-Commodity1 month ago Zydus gets USFDA nod for anti-hypertensive drug  Hindu Business Line1 month ago
[x]  

Guj Alkalies appoints Cadila Pharma CMD as Ind Dir

New Delhi, Oct 9 (PTI) State-run Gujarat Alkalies and Chemicals Ltd has appointed Cadila Pharmaceuticals CMD Rajiv Modi as an independent director on its board. The company has also appointed Pallavi Shroff as an independent director. Shroff, who ...
 Press Trust of India2 weeks ago Gujarat Alkalies Appoints Cadila Pharma CMD as Independent Director  NDTV2 weeks ago

Cadila Pharma encourages employees to take break and dance on Garba tunes

AHMEDABAD: Gujarat-based drug maker Cadila Pharmaceuticals Ltd organised Navratri festival at its campus to encourage their employees to take a break from their cubicle and let their dandiya sticks do the talking. Cadila branded the navratri as ...
 Economic Times3 weeks ago
Business Standard India

Zydus Cadila bags license for hepatitis C drug

Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment ...
 Sify1 month ago Zydus plans to have 15 biologic products in two years  Business Standard India3 weeks ago Zydus granted license to produce generic hepatitis C drug  Smart Investor1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less